Milan, Italy, August 20th, 2015 - Sorin S.p.A., (MTA; Reuters Code: SORN.MI, "Sorin"), a global medical device company and a leader in the treatment of cardiovascular diseases today announced a favorable ruling for Sorin over the previously communicated creditor rights objection claim brought by the State's Attorney of Milan (Avvocato dello Stato di Milano or the "Italian State's Attorney") to enjoin the planned combination of Sorin and Cyberonics (the "Transaction") under a newly formed holding company, LivaNova PLC ("LivaNova").

click here to view the release

distributed by